跳至主要内容
临床试验/ACTRN12612001221842
ACTRN12612001221842已完成2 期

Randomised Double Blind Placebo Controlled Study to Determine the Effects of Vitamin D supplementation on Platelet and Vascular function in patients with Vitamin D insufficiency and known Coronary artery or peripheral vascular disease

Alfred Health0 个研究点目标入组 40 人开始时间: 2012年11月19日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
Alfred Health
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
40 Years 至 85 Years(—)
性别
All

入选标准

  • Measured Vitamin D level 25-50 nanomol/L
  • Not on Vitamin D replacement therapy for previous 3 months
  • Known history of CAD or PVD
  • Currently taking Aspirin as single anti-platelet therapy
  • Other appropriate arterial disease risk factor reduction therapy

排除标准

  • Age < 40yrs or > 85yrs
  • Measured Vitamin D level < 25nmol/L
  • History of osteoporosis or low-impact fractures
  • Current or planned prenancy
  • Severe renal impairment (eGFR < 30)
  • Current or previous hypercalcemia
  • Known secondary cause of vitamin D insufficiency (eg. malabsorptive states)
  • Presence of an active malignancy
  • Liver cirrhosis
  • Planned coronary artery or peripheral vascular intervention within next 6 months
  • Current oral anticoagulation therapy (eg. Warfarin, Dabigatran)
  • Clopidogrel or anti-epileptic therapy at any stage of the trial periodoAny known hypersensitivity to Vitamin D (cholecalciferol)

研究者

发起方
Alfred Health

相似试验

Randomised Double Blind Placebo Controlled Study to... | 临床试验